Rexgenero treats first patients in CLI trial – PharmaTimes

January 30, 2018

London, UK-based Rexgenero has reached a major milestone in treating the first patient in a late-stage trial with its lead product, cell therapy REX-001. – News – PharmaTimes

Source: Rexgenero treats first patients in CLI trial – PharmaTimes

Comments

comments